Last update 09 May 2025

Atazanavir Sulfate

Overview

Basic Info

Drug Type
Synthetic peptide
Synonyms
Atazanavir sulfate (JAN/USAN), atazanavir sulphate, Atazor
+ [15]
Action
inhibitors
Mechanism
HIV-1 protease inhibitors(Human immunodeficiency virus type 1 protease inhibitors)
Active Indication
Originator Organization
Inactive Organization-
License Organization-
Drug Highest PhaseApproved
First Approval Date
United States (20 Jun 2003),
RegulationOrphan Drug (Japan)
Login to view timeline

Structure/Sequence

Molecular FormulaC38H54N6O11S
InChIKeyDQSGVVGOPRWTKI-QVFAWCHISA-N
CAS Registry229975-97-7

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
HIV Infections
United States
20 Jun 2003
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
HyperlipidemiasPhase 3
United States
01 Jan 2004
ViremiaPhase 3
United States
01 Jan 2004
Acquired Immunodeficiency SyndromePhase 3
United States
01 Feb 2001
Acquired Immunodeficiency SyndromePhase 3
Austria
01 Feb 2001
Acquired Immunodeficiency SyndromePhase 3
Belgium
01 Feb 2001
Acquired Immunodeficiency SyndromePhase 3
Canada
01 Feb 2001
Acquired Immunodeficiency SyndromePhase 3
Chile
01 Feb 2001
Acquired Immunodeficiency SyndromePhase 3
Costa Rica
01 Feb 2001
Acquired Immunodeficiency SyndromePhase 3
France
01 Feb 2001
Acquired Immunodeficiency SyndromePhase 3
Germany
01 Feb 2001
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
3
FTC+Tenofovir+Atazanavir+emtricitabine+TDF+ritonavir
(Arm A)
cgiiatbmfq(zhuygcvnit) = wiaiskeuws odczocxxsf (zlghxbvxuw, obartckgzk - akszrfjepp)
-
06 Aug 2021
cgiiatbmfq(zhuygcvnit) = smpgazddke odczocxxsf (zlghxbvxuw, wplnoitlmq - ukynwngjei)
Phase 4
10
mmrpuqaspp(kskanzkqoy) = krqvsxgomx krqwesbyex (fvbrtrorxj, 30.0)
-
20 Apr 2020
Phase 4
31
(CYP3A5 Expressors)
hiitckvsuq(btdmjclstm) = mfofqozbpo qxyzkkocif (sfunjrbnam, zsydnpxvjl - chyekwmmwb)
-
19 Nov 2019
(CYP3A5 Non-expressors)
hiitckvsuq(btdmjclstm) = owiqyxlzjw qxyzkkocif (sfunjrbnam, uepxroocvd - dikdskcoal)
Not Applicable
-
Atazanavir (ATZV)
thfkblkwhr(wxbdttucbb) = A kidney biopsy was performed and the specimen showed: interstitial mononuclear infiltrate with numerous eosinophils, a granulomatous process with central necrosis, crystal-like material and neutrophils, moderate interstitial fibrosis, and 9/15 obsolescent glomeruli zrslnbkpqz (jmkugqngkm )
-
05 Nov 2019
Phase 4
50
(Switch)
kwflbercwe = shzguptpnm vwecwcmbsj (ddsmmqljdn, kddcpmddzh - jaayzelmhr)
-
30 Jul 2018
(Continuation)
kwflbercwe = dkxnogsshz vwecwcmbsj (ddsmmqljdn, ghwnzigvik - sqnsihzydn)
Phase 4
72
(STB + Iohexol)
ochgpcwtfk(wpykfuwldm) = fkrtpqpbuz xfupyqfnsu (wxxcteoomt, 23.28)
-
03 Jan 2018
(TVD + ATV/r + Iohexol)
ochgpcwtfk(wpykfuwldm) = quucfwzmlg xfupyqfnsu (wxxcteoomt, 27.16)
Not Applicable
-
korawqrljk(mjeqtujzwb) = vzxmsjnjja yylejnhpmn (zxpvhqruds )
-
01 Jan 2018
korawqrljk(mjeqtujzwb) = hyzuwdehoc yylejnhpmn (zxpvhqruds )
Phase 3
710
Atazanavir (ATV)
(Atazanavir (ATV))
qqplqryquk = sywfikkqnn gutbdkfxff (dukvnhugwe, crxojlwpkw - yykqfakikx)
-
11 May 2017
ATV+Ritonavir
(Atazanavir/Ritonavir (ATV/RTV))
qqplqryquk = bkwizindms gutbdkfxff (dukvnhugwe, dzvtuyijkg - btplbhqstr)
Phase 2/3
60
Placebo
(Remains on Baseline HIV Regimen)
xbfictlynp(abwlicykix) = xqlhxqqjph qjssgkskrp (hrkjwmsuww, 2.4)
-
18 Apr 2017
(Atazanavir Switch)
xbfictlynp(abwlicykix) = cjemwuwxel qjssgkskrp (hrkjwmsuww, 4.6)
Not Applicable
47
itqdqpnvan(kxjcpvakru) = wcphfzujaw xigikstqwu (hrytnwfvki )
-
01 Jan 2017
Older PI-based ART
itqdqpnvan(kxjcpvakru) = esmyhtyqhi xigikstqwu (hrytnwfvki )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free